Antonio Pisani,
#163,882
Most Influential Person Now
Antonio Pisani,'s AcademicInfluence.com Rankings
Antonio Pisani,biology Degrees
Biology
#13153
World Rank
#16681
Historical Rank
Neuroscience
#2264
World Rank
#2325
Historical Rank
Download Badge
Biology
Antonio Pisani,'s Degrees
- PhD Neuroscience University of Milan
- Bachelors Biology University of Milan
Similar Degrees You Can Earn
Why Is Antonio Pisani, Influential?
(Suggest an Edit or Addition)Antonio Pisani,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease (2009) (1167)
- Long-term synaptic depression in the striatum: physiological and pharmacological characterization (1992) (676)
- Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 (2005) (517)
- Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice (2007) (514)
- The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia (1996) (464)
- Acetylcholine-mediated modulation of striatal function (2000) (438)
- Re-emergence of striatal cholinergic interneurons in movement disorders (2007) (411)
- Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels (1992) (404)
- Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons (2001) (309)
- R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice (2009) (295)
- Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors (1997) (294)
- Synaptic transmission in the striatum: from plasticity to neurodegeneration (2000) (275)
- Distinct Roles of D1 and D5 Dopamine Receptors in Motor Activity and Striatal Synaptic Plasticity (2003) (244)
- Receptor Subtypes Involved in the Presynaptic and Postsynaptic Actions of Dopamine on Striatal Interneurons (2003) (234)
- A Critical Role of the Nitric Oxide/cGMP Pathway in Corticostriatal Long-Term Depression (1999) (222)
- Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models (2020) (213)
- Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones (1997) (209)
- The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life (2012) (202)
- Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. (2009) (187)
- Post-receptor mechanisms underlying striatal long-term depression (1994) (182)
- Inhibition of Mitochondrial Complex II Induces a Long-Term Potentiation of NMDA-Mediated Synaptic Excitation in the Striatum Requiring Endogenous Dopamine (2001) (165)
- Activation of D2-Like Dopamine Receptors Reduces Synaptic Inputs to Striatal Cholinergic Interneurons (2000) (161)
- Endogenous ACh enhances striatal NMDA‐responses via M1‐like muscarinic receptors and PKC activation (1998) (159)
- Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases (2004) (153)
- High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients (2005) (153)
- Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease (2005) (151)
- Synaptic plasticity in the ischaemic brain (2003) (145)
- Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia (2006) (143)
- Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study (2009) (141)
- Abnormal plasticity in dystonia: Disruption of synaptic homeostasis (2011) (138)
- Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease (1998) (132)
- Endogenous Serotonin Excites Striatal Cholinergic Interneurons via the Activation of 5-HT 2C, 5-HT6, and 5-HT7 Serotonin Receptors: Implications for Extrapyramidal Side Effects of Serotonin Reuptake Inhibitors (2007) (131)
- Impaired dopamine release and synaptic plasticity in the striatum of Parkin−/− mice (2009) (131)
- Dystonia (1996) (130)
- Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine (2004) (125)
- Dopamine, Acetylcholine and Nitric Oxide Systems Interact to Induce Corticostriatal Synaptic Plasticity (2003) (123)
- Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia (2015) (120)
- Effects of Two Weeks of Cerebellar Theta Burst Stimulation in Cervical Dystonia Patients (2014) (118)
- Activation of Group III Metabotropic Glutamate Receptors Depresses Glutamatergic Transmission at Corticostriatal Synapse (1997) (118)
- Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease (2006) (117)
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease (2012) (117)
- Centrality of Striatal Cholinergic Transmission in Basal Ganglia Function (2011) (116)
- Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (2019) (109)
- Selective involvement of mGlu1 receptors in corticostriatal LTD (2001) (108)
- Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum (1997) (106)
- Critical role of calcitonin gene-related peptide receptors in cortical spreading depression (2012) (104)
- Early synaptic dysfunction in Parkinson's disease: Insights from animal models (2016) (104)
- Metabotropic Glutamate Receptors and Cell-Type-Specific Vulnerability in the Striatum: Implication for Ischemia and Huntington's Disease (1999) (103)
- Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. II. Modulation of High‐Voltage‐Activated Calcium Currents (1995) (101)
- Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro Ischemia (2006) (99)
- On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. (1995) (98)
- Selective Blockade of Type-1 Metabotropic Glutamate Receptors Induces Neuroprotection by Enhancing Gabaergic Transmission (2001) (98)
- Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum (2004) (97)
- Targeting striatal cholinergic interneurons in Parkinson’s disease: Focus on metabotropic glutamate receptors (2003) (96)
- Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons (1994) (96)
- Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia (2010) (93)
- Cocaine and Amphetamine Depress Striatal GABAergic Synaptic Transmission through D2 Dopamine Receptors (2002) (90)
- Muscarinic IPSPs in rat striatal cholinergic interneurones (1998) (89)
- Loss of Muscarinic Autoreceptor Function Impairs Long-Term Depression But Not Long-Term Potentiation in the Striatum (2008) (89)
- Cholinergic Dysfunction Alters Synaptic Integration between Thalamostriatal and Corticostriatal Inputs in DYT1 Dystonia (2012) (87)
- Activation of dopamine D1‐like receptors excites LTS interneurons of the striatum (2002) (86)
- Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. (2005) (86)
- Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors (2002) (85)
- Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons (2006) (83)
- The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection (2020) (81)
- Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase (1995) (81)
- Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia (2009) (81)
- Hyperkinetic disorders and loss of synaptic downscaling (2016) (79)
- Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. (1999) (79)
- Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal Synapses (1997) (79)
- Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors (2014) (78)
- Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons (2005) (77)
- Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. (2002) (76)
- Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons (1997) (75)
- Developmental Profile of the Aberrant Dopamine D2 Receptor Response in Striatal Cholinergic Interneurons in DYT1 Dystonia (2011) (72)
- Metabotropic Glutamate 2 Receptors Modulate Synaptic Inputs and Calcium Signals in Striatal Cholinergic Interneurons (2002) (72)
- An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons (1999) (71)
- Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. (2002) (70)
- Generation of a novel rodent model for DYT1 dystonia (2012) (69)
- Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA–Induced Dyskinesia (2016) (68)
- Heterogeneity of Metabotropic Glutamate Receptors in the Striatum: Electrophysiological Evidence (1993) (68)
- NR2B Subunit Exerts a Critical Role in Postischemic Synaptic Plasticity (2006) (68)
- Role of tonically-active neurons in the control of striatal function: Cellular mechanisms and behavioral correlates (2001) (67)
- Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease (2007) (67)
- Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA (2012) (65)
- Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia (2014) (65)
- Blockade of M2‐like muscarinic receptors enhances long‐term potentiation at corticostriatal synapses (1998) (64)
- Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons (2001) (64)
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients (2010) (64)
- Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence (2019) (63)
- Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson’s disease patients (2008) (63)
- Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment (2009) (61)
- L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons. (1998) (60)
- Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine (2010) (59)
- Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons (2001) (58)
- Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. I. Modulation of Corticostriatal Synaptic Transmission (1995) (57)
- Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism (2005) (57)
- Systemic Activation of Nrf2 Pathway in Parkinson's Disease (2020) (56)
- Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy (2020) (55)
- GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort (2020) (55)
- Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease (2004) (54)
- Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease. (2006) (53)
- Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase (2006) (53)
- Pisa syndrome in Parkinson disease (2015) (53)
- Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum (2018) (52)
- Tissue plasminogen activator is required for corticostriatal long‐term potentiation (2002) (52)
- Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. (2001) (51)
- Deep brain stimulation in Parkinson's disease patients: biochemical evidence. (2006) (51)
- Inhibition of Persistent Sodium Current Fraction and Voltage‐gated L‐type Calcium Current by Propofol in Cortical Neurons: Implications for Its Antiepileptic Activity (2005) (50)
- Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation. (1999) (50)
- Stimulation of Nitric Oxide–cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation (2001) (50)
- Homeostatic changes of the endocannabinoid system in Parkinson's disease (2011) (50)
- Electrophysiological actions of felbamate on rat striatal neurones (1995) (49)
- Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. (1998) (49)
- Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons. (1996) (46)
- Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease. (2009) (46)
- Activation of β1-Adrenoceptors Excites Striatal Cholinergic Interneurons through a cAMP-Dependent, Protein Kinase-Independent Pathway (2003) (45)
- Chronic Cocaine Prevents Depotentiation at Corticostriatal Synapses (2006) (44)
- Engineering animal models of dystonia (2013) (44)
- Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review (2021) (44)
- Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons (2015) (44)
- Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum (2013) (44)
- Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin (2009) (44)
- New genetic insights highlight ‘old’ ideas on motor dysfunction in dystonia (2013) (43)
- Lithium Treatment Blocks Long-Term Synaptic Depression in the Striatum (1993) (43)
- PINK1 heterozygous mutations induce subtle alterations in dopamine‐dependent synaptic plasticity (2014) (42)
- Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons (1998) (42)
- Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease (2007) (42)
- Dystonia as a network disorder: a concept in evolution (2018) (41)
- An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study. (2015) (40)
- Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown (2020) (40)
- Antiepileptic Drugs on Calcium Currents Recorded from Cortical and PAG Neurons: Therapeutic Implications for Migraine (2008) (39)
- Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease. (2018) (39)
- Transmitter Release Associated with Long‐term Synaptic Depression in Rat Corticostriatal Slices (1995) (39)
- The neurobiological bases of autism spectrum disorders: the R451C‐neuroligin 3 mutation hampers the expression of long‐term synaptic depression in the dorsal striatum (2018) (38)
- A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices (1996) (37)
- Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission (2011) (37)
- RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models (2018) (37)
- Dystonia and dopamine: From phenomenology to pathophysiology (2019) (35)
- Calcium signaling and neuronal vulnerability to ischemia in the striatum. (2004) (35)
- Centrality of Early Synaptopathy in Parkinson’s Disease (2018) (35)
- Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain (2015) (35)
- A Clinical and Biochemical Analysis in the Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus (2015) (35)
- Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism (2005) (34)
- Distinct roles of group I mGlu receptors in striatal function (2008) (34)
- Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia (2015) (33)
- Involvement of Intracellular Calcium Stores during Oxygen/Glucose Deprivation in Striatal Large Aspiny Interneurons (2000) (32)
- Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus (2018) (31)
- Role of Ca2+ in striatal LTD and LTP (1996) (31)
- Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice (2016) (31)
- Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology (2020) (30)
- Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine (2006) (30)
- SHORT COMUNICATIONEarly sodium elevations induced by combined oxygen and glucose deprivation in pyramidal cortical neurons (1998) (29)
- Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study (2020) (29)
- Assessment of Motor Impairments in Early Untreated Parkinson's Disease Patients: The Wearable Electronics Impact (2020) (29)
- Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia (2014) (27)
- CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients. (2019) (27)
- Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features (2020) (27)
- Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition (2017) (27)
- Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. (2004) (26)
- Stimulus frequency, calcium levels and striatal synaptic plasticity (2003) (25)
- Cell-type specificity of mGluR activation in striatal neuronal subtypes (2000) (25)
- EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic (2020) (25)
- The Italian Dystonia Registry: rationale, design and preliminary findings (2017) (24)
- Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson’s disease: a systematic review and meta-analysis (2018) (24)
- The neuroligins and the synaptic pathway in Autism Spectrum Disorder (2020) (23)
- Torsin A Localization in the Mouse Cerebellar Synaptic Circuitry (2013) (23)
- Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons (2004) (23)
- Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies. (2006) (23)
- Metabotropic glutamate receptors and neuronal toxicity. (1992) (22)
- Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons (2015) (22)
- The modulation of calcium currents by the activation of mGluRs (1996) (22)
- Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum (2008) (21)
- Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD). (2016) (21)
- Anatomical and psychological mechanism of reduplicative misidentification syndromes (2000) (21)
- Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. (1999) (20)
- Hypoglycemia, Hypoxia, and Ischemia in a Corticostriatal Slice Preparation: Electrophysiologic Changes and Ascorbyl Radical Formation (1998) (20)
- A Possible Mechanism for the Aglycemia-Induced Depression of Glutamatergic Excitation in the Striatum (1997) (19)
- Hypoxia-Induced Electrical Changes in Striatal Neurons (1995) (19)
- The neurobiological basis for novel experimental therapeutics in dystonia (2019) (18)
- Excess Lipin enzyme activity contributes to TOR1A recessive disease and DYT-TOR1A dystonia. (2020) (18)
- Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease (2019) (17)
- Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? (2020) (17)
- Assessment of serum uric acid as risk factor for tauopathies (2017) (17)
- Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (17)
- Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia (2018) (17)
- Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients (2021) (17)
- Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia (2020) (16)
- Heidenhain variant in two patients with inherited V210I Creutzfeldt–Jakob disease (2015) (16)
- Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy (2018) (16)
- Hypoxia in striatal and cortical neurones: membrane potential and Ca2+ measurements (1997) (16)
- Presynaptic modulation by group III metabotropic glutamate receptors (mGluRs) of the excitatory postsynaptic potential mediated by mGluR1 in rat cerebellar Purkinje cells (2001) (16)
- Functional motor phenotypes: to lump or to split? (2021) (16)
- Functional and ultrastructural analysis of group I mGluR in striatal fast‐spiking interneurons (2007) (15)
- Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders (2012) (15)
- Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia (2017) (15)
- Facemasks and face recognition: Potential impact on synaptic plasticity (2021) (15)
- Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease (2011) (15)
- Seletracetam (ucb 44212) inhibits high‐voltage–activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro (2009) (15)
- Aberrant striatal synaptic plasticity in monogenic parkinsonisms (2012) (15)
- A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: The NeuroCOVID‐19 Task Force of the European Academy of Neurology (2021) (15)
- The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease (2020) (14)
- Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease. (2019) (14)
- Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study. (2018) (14)
- Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1‐deficient mice (2016) (14)
- A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms. (2020) (14)
- Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data. (2020) (14)
- Faculty Opinions recommendation of PINK1-linked parkinsonism is associated with Lewy body pathology. (2010) (14)
- Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia (2020) (13)
- Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis (2020) (13)
- Outward potassium currents activated by depolarization in rat globus pallidus (1995) (13)
- Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction (2018) (13)
- Behavioural learning‐induced increase in spontaneous GABAA‐dependent synaptic activity in rat striatal cholinergic interneurons (2003) (12)
- Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (2016) (12)
- Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson’s Disease (2019) (12)
- Experimental models of dystonia. (2011) (12)
- Promising rodent models in Parkinson's disease. (2018) (11)
- Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia. (2020) (11)
- Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study (2019) (11)
- Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission. (1997) (11)
- Primary prevention of COVID‐19: Advocacy for vaccination from a neurological perspective (2021) (11)
- Isolated Hemidystonia Associated with NMDa Receptor Antibodies (2011) (10)
- The modulation of dopamine receptors in rat striatum. (1995) (10)
- Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation (2002) (10)
- Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy (2020) (10)
- Rotigotine may control drooling in patients with Parkinson’s Disease: Preliminary findings (2017) (10)
- Reversal of dopamine‐mediated firing inhibition through activation of the dopamine transporter in substantia nigra pars compacta neurons (2018) (9)
- Wearable Electronics Assess the Effectiveness of Transcranial Direct Current Stimulation on Balance and Gait in Parkinson’s Disease Patients (2019) (9)
- Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia. (2021) (9)
- The effect of postural deformities on back function and pain in patients with Parkinson's disease. (2019) (9)
- Impairment of mitochondrial metabolism differentially affects striatal neuronal subtypes (2002) (8)
- Does Pisa syndrome affect upper limb function in patients with Parkinson's disease? An observational cross-sectional study. (2018) (8)
- Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (2019) (8)
- Levodopa-induced dyskinesia and striatal signaling pathways (2009) (8)
- Morphological and functional study of dwarf neurons in the rat striatum (1998) (8)
- Weak effect of neuromodulators on climbing fiber-activated [Ca2+]i increases in rat cerebellar Purkinje neurons (1999) (8)
- Models of dystonia: an update (2020) (8)
- Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia (2017) (8)
- Hypoxic and hypoglycaemic changes of intracellular pH in cerebral cortical pyramidal neurones (1998) (8)
- CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone—a case report (2014) (8)
- Dystonia: Are animal models relevant in therapeutics? (2018) (8)
- Voice in Parkinson's Disease: A Machine Learning Study (2022) (7)
- The influence of postural deformities on neck function and pain in patients with Parkinson's disease. (2019) (7)
- Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? (2017) (7)
- Neuroacanthocytosis associated with a defect of the 4.1R membrane protein (2007) (7)
- Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease (2022) (7)
- Electrophysiology of 5-HT6 receptors. (2010) (7)
- From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome (2021) (6)
- Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy (2020) (6)
- Facial diplegia resembling bilateral Ramsay Hunt Syndrome (2017) (6)
- Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process. (2013) (6)
- LONG-TERM CHANGES OF CORTICOSTRIATAL SYNAPTIC TRANSMISSION: POSSIBLE IMPLICATION FOR MOTOR MEMORY (1995) (6)
- Rescue of striatal long-term depression by chronic mGlu5 receptor negative allosteric modulation in distinct dystonia models (2021) (6)
- Author Correction: Dystonia (2018) (6)
- Electrophysiology of dopamine D-1 receptors in the basal ganglia: Old facts and new perspectives (1995) (6)
- Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report (2013) (5)
- Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry (2020) (5)
- Adult-onset sporadic chorea: real-world data from a single-centre retrospective study (2021) (5)
- Effects of head trauma and sport participation in young-onset Parkinson’s disease (2021) (5)
- Persistent chorea in DYT6, due to anticholinergic therapy. (2015) (5)
- Towards a new era for dystonia, a high priority for biomedical research (2011) (5)
- Assessment of Hearing Impairment in Parkinson's Disease: Implications for Differential Diagnosis and Disease Progression (2017) (5)
- Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson's Disease. (2020) (5)
- Putaminal, but not nigral alterations, characterize hemiparkinsonism‐hemiatrophy syndrome: A case report (2011) (5)
- Outlining a Population “at Risk” of Parkinson's Disease: Evidence from a Case-Control Study (2016) (5)
- Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction (2022) (4)
- Neuroimaging in idiopathic adult-onset focal dystonia (2021) (4)
- X‐Linked Parkinsonism: Phenotypic and Genetic Heterogeneity (2021) (4)
- Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases (2019) (4)
- Second hit hypothesis in dystonia: Dysfunctional cross talk between neuroplasticity and environment? (2021) (4)
- Actions of Glycine on Non‐dopaminergic Neurons of the Rat Substantia Nigra (1995) (4)
- Biofluids profile of α-Klotho in patients with Parkinson's disease. (2021) (4)
- Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort (2021) (3)
- Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit (2016) (3)
- A novel analytical approach to assess dyskinesia in patients with Parkinson disease (2018) (3)
- Functional gait disorders: Demographic and clinical correlations. (2021) (3)
- Long-term changes of synaptic transmission: A topic of long-term interest (1996) (3)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site. (2021) (3)
- Double hit mouse model of Parkinson's disease (2016) (3)
- Inhibition of Lipin lipid phosphatase hyperactivity rescues TorsinA neurological disease (2019) (3)
- Long-term treatment with rotigotine in drug-naïve PSP patients (2018) (3)
- A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice (2021) (3)
- Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia (2021) (2)
- The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait (2021) (2)
- Basic research in substantia nigra and ventral tegmental area: clinical implications. (1995) (2)
- Generalized Finite-Length Fibonacci Sequences in Healthy and Pathological Human Walking: Comprehensively Assessing Recursivity, Asymmetry, Consistency, Self-Similarity, and Variability of Gaits (2021) (2)
- Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report (2017) (2)
- Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia (2021) (2)
- Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A (2021) (2)
- Clinical course of paroxysmal dyskinesias throughout pregnancy. (2020) (2)
- Author response: Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum (2018) (2)
- Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2 (2022) (2)
- Dopaminergic involvement in a drummer with focal dystonia: A case study (2018) (2)
- The Impact of Wearable Electronics in Assessing the Effectiveness of Levodopa Treatment in Parkinson's Disease (2022) (2)
- Vocal test Analysis for Assessing Parkinson's Disease at Early Stage (2021) (2)
- The Retinal Posterior Pole in Early Parkinson’s Disease: A Fundus Perimetry and SD-OCT Study (2021) (2)
- Basic Electrophysiology and Possible New Therapeutic Approaches to Movement Disorders (1994) (1)
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease (2012) (1)
- Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (1)
- S-8-4 D2 dopamine receptors in the short- and long-term modulation of corticostriatal transmission (1996) (1)
- Comments on: "Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review". (2018) (1)
- Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial (2022) (1)
- 33° National Congress of the Italian Society for the Study of Headaches Naples (Italy), June 14 – 16, 2019 (2019) (1)
- Sudden Onset, Fixed Dystonia and Acute Peripheral Trauma as Diagnostic Clues for Functional Dystonia (2021) (1)
- Synaptic effects of ethanol on striatal circuitry: therapeutic implications for dystonia (2021) (1)
- DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family. (2022) (1)
- Different mouse genetic models of human DYT1 dystonia share changes of phosphodiesterase-10A in basal ganglia circuits. (2015) (0)
- A naturalistic observation on 20 consecutive patients under LCIG at the “Tor Vergata” University; enforced counseling and alternative route of LD delivery for avoiding discontinuation? (2018) (0)
- Short and Long Term Modulation of Synaptic Activity in Striatal Cholinergic Interneurons (2005) (0)
- 52nd Congress of the Italian Association of Neuropathology and Clinical Neurobiology (AINPeNC) and 42nd Congress of the Italian Association for Research on Brain Aging (AIRIC) Rome, Italy, May 26 – 28, 2016 (2016) (0)
- Group I mGluRs enhance NMDA responses in the striatum (1996) (0)
- Review for "Cholinergic modulation of striatal nitric oxide‐producing interneurons" (2019) (0)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site, data from the Italian dystonia registry (2021) (0)
- CSF level of anti-aging protein Α-klotho is inversely associated with Α-synuclein in Parkinson's disease patients (2021) (0)
- Editorial for neurobiology of disease special issue on dystonia progress in the neurobiology of dystonia (2019) (0)
- Long-term treatment with rotigotine in drug-naïve PSP patients (2018) (0)
- Glutamate Transmission in the Pathogenesis of Parkinson’s Disease (2004) (0)
- Review for "Reciprocal interaction between striatal cholinergic and low threshold spiking interneurons ‐ a computational study" (2020) (0)
- Dopamine-Dependent Long-Term Potentiation Induced by 3-Nitropropionic Acid in Striatal Medium Spiny Neurons (2002) (0)
- SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS (1993) (0)
- Parkin,DJ‐1,PINK1ノックアウトマウスにおける共通の分子病態生理 (2007) (0)
- Neuroscience disease models (2012) (0)
- Direct and synaptic effect of metabotropic glutamate receptors on striatal cholinergic interneurons excitability (2001) (0)
- Corrigendum to “Dystonia and dopamine: From phenomenology to pathophysiology” [Prog. Neurobiol. 182 (November) (2019), 101678, 18] (2020) (0)
- A2A receptors in mouse model of DYT1 primary dystonia (2021) (0)
- The concept of "neuroprotection" in neurological diseases (2004) (0)
- OPTH_A_323944 4005..4014 (2021) (0)
- Isolated Hemidystonia Associated with NMDa Receptor Antibodies Introduction (2011) (0)
- Role of mGluRs in the modulation of synaptic activity of different striatal neuronal subtypes (1996) (0)
- P-11-37 Actions of the anticonvulsant felbamate on striatal neurons (1995) (0)
- Torsin-a DYT1-transgenic mice overexpress phosphodiesterase 10A in striato-nigral and striato-pallidal pathways. (2013) (0)
- Faculty Opinions recommendation of Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. (2011) (0)
- Moderate-severe obstructive sleep apnea and the risk for preclinical Alzheimer's disease biomarkers changes (2017) (0)
- The effects of neurorehabilitation on sequence effect in Parkinson's disease patients with and without freezing of gait (2021) (0)
- Periphery is central to nociception (2002) (0)
- Review for "Maladaptive striatal plasticity and abnormal reward‐learning in cervical dystonia" (2019) (0)
- Iconographies supplémentaires de l'article : Dystonia: Are animal models relevant in therapeutics? (2018) (0)
- Review for "What’s wrong with the striatal cholinergic interneurons in Parkinson’s disease? Focus on intrinsic excitability" (2020) (0)
- FULL-LENGTH ORIGINAL RESEARCH (2009) (0)
- Dopaminergic agonists and l-dopa (2009) (0)
- The guam toxin, B-N-methylamino-L-alanine (BMAA) activates metabotropic glutamate receptors in brain slices and neuronal cultures (1990) (0)
- Biochemical Markers of DBS-Induced Transition from “Off” to “On” State in Parkinsonian Patients (2005) (0)
- CALCIUM: THE DIRECTOR OF OUR MEMORY PROCESSES (2001) (0)
- Erratum to: Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia. (2021) (0)
- 3-31-18 Brief psychotherapy in patients with multiple sclerosis (1997) (0)
- Cholinergic Interneuron and Parkinsonism (2009) (0)
- 6 Dopamine CSF metabolites as reliable stage biomarkers of early Parkinson’s disease (2012) (0)
- Technology based prognostic biomarkers in Parkinson's disease: A prospective study in a de novo cohort (2021) (0)
- Faculty Opinions recommendation of Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. (2010) (0)
- Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. (2020) (0)
- Ras-grf1 regulates striatum-dependent behavioural plasticity, long term synaptic signalling and responses to drugs of abuse (2004) (0)
- L-Type Ca 2 (cid:49) Channel Blockers Attenuate Electrical Changes and Ca 2 (cid:49) Rise Induced by Oxygen/Glucose Deprivation in Cortical Neurons (1998) (0)
- Editorial Board (2011) (0)
- Selective increase in sensitivity to group II mGluR activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin (2008) (0)
- Rescue of striatal long-term depression by chronic MGLU5 receptor negative allosteric modulation in distinct dystonia models (2021) (0)
- Neuromodulatory functions exerted by oxytocin on different populations of hippocampal neurons in rodents (2023) (0)
- Adult onset sporadic chorea: A single-centre retrospective study (2021) (0)
- Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (2018) (0)
- Plasticity, genetics and epigenetics in dystonia: An update (2022) (0)
- Axial postural abnormalities and pain in Parkinson’s disease (2022) (0)
- How relevant is the cholinergic system in DYT1 dystonia (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonio Pisani,?
Antonio Pisani, is affiliated with the following schools:
